KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Shares Issued (2016 - 2025)

Nu Skin Enterprises' Shares Issued history spans 17 years, with the latest figure at -$741000.0 for Q4 2025.

  • For Q4 2025, Shares Issued fell 1155.93% year-over-year to -$741000.0; the TTM value through Dec 2025 reached -$1.9 million, up 7.32%, while the annual FY2025 figure was -$1.9 million, 7.32% up from the prior year.
  • Shares Issued for Q4 2025 was -$741000.0 at Nu Skin Enterprises, down from -$29000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $21.1 million in Q2 2022 and bottomed at -$1.9 million in Q1 2024.
  • The 5-year median for Shares Issued is -$4500.0 (2025), against an average of $2.1 million.
  • The largest annual shift saw Shares Issued soared 837.11% in 2022 before it tumbled 1155.93% in 2025.
  • A 5-year view of Shares Issued shows it stood at $6.0 million in 2021, then plummeted by 78.99% to $1.3 million in 2022, then plummeted by 114.31% to -$180000.0 in 2023, then surged by 67.22% to -$59000.0 in 2024, then crashed by 1155.93% to -$741000.0 in 2025.
  • Per Business Quant, the three most recent readings for NUS's Shares Issued are -$741000.0 (Q4 2025), -$29000.0 (Q3 2025), and $20000.0 (Q2 2025).